FDA sends Procter & Gamble a warning

Sep 18, 2007

The U. S. Food and Drug Administration has warned the Procter & Gamble Co. about claims it makes for its Vicks Early Defense Foaming Hand Sanitizer.

The agency said the product's claims and directions for use cause it to be an unapproved new drug under the Federal Food, Drug, and Cosmetic Act.

The FDA specifically citied P&G for promoting Early Defense for use by schoolchildren to prevent colds and to provide antimicrobial activity for up to three hours. Officials said the product has not been proven safe and effective for such claims.

Under its drug monograph system, the FDA allows OTC drugs to be marketed without first obtaining agency approval in certain circumstances. Such drugs must comply with applicable standards regarding monographs that specify conditions for the drugs' labeling and formulation.

In the Procter & Gamble case, the Cincinnati-headquartered company's claims the product prevents colds and provides up to three hours of antimicrobial activity are not allowed.

Copyright 2007 by United Press International

Explore further: Experts call for higher exam pass marks to close performance gap between international and UK medical graduates

add to favorites email to friend print save as pdf

Related Stories

Drugmakers eliminate infant drops of key medicine

May 05, 2011

(AP) -- Johnson & Johnson and other makers of cold and fever medications said Wednesday that they will discontinue infant drops of medicines containing acetaminophen in an effort to avoid confusion that can lead to dangerous ...

FDA warns of fractures with osteoporosis drugs

Oct 13, 2010

(AP) -- Government health officials warned doctors and patients Wednesday about an increased risk of thigh fractures with a widely used group of bone-strengthening drugs.

FDA looks to curb abuse of cough medicine

Aug 31, 2010

(AP) -- Federal health regulators are weighing restrictions on Robitussin, NyQuil and other cough suppressants to curb cases of abuse that send thousands of people to the hospital each year.

FDA: 'Female Viagra' falls short

Jun 16, 2010

(AP) -- The first pill designed to boost the female sex drive failed to make a significant impact on libido in two studies, federal health regulators said, though some women did report slightly more sexually ...

Recommended for you

What are the chances that your dad isn't your dad?

Apr 16, 2014

How confident are you that the man you call dad is really your biological father? If you believe some of the most commonly-quoted figures, you could be forgiven for not being very confident at all. But how ...

New technology that is revealing the science of chewing

Apr 15, 2014

CSIRO's 3D mastication modelling, demonstrated for the first time in Melbourne today, is starting to provide researchers with new understanding of how to reduce salt, sugar and fat in food products, as well ...

After skin cancer, removable model replaces real ear

Apr 11, 2014

(HealthDay)—During his 10-year struggle with basal cell carcinoma, Henry Fiorentini emerged minus his right ear, and minus the hearing that goes with it. The good news: Today, the 56-year-old IT programmer ...

User comments : 0

More news stories

Treating depression in Parkinson's patients

A group of scientists from the University of Kentucky College of Medicine and the Sanders-Brown Center on Aging has found interesting new information in a study on depression and neuropsychological function in Parkinson's ...